Antimicrobial resistance with Streptococcus pneumoniae in the United States, 1997 98
- PMID: 10603208
- PMCID: PMC2640814
- DOI: 10.3201/eid0506.990603
Antimicrobial resistance with Streptococcus pneumoniae in the United States, 1997 98
Abstract
From November 1997 to April 1998, 1,601 clinical isolates of Streptococcus pneumoniae were obtained from 34 U.S. medical centers. The overall rate of strains showing resistance to penicillin was 29. 5%, with 17.4% having intermediate resistance. Multidrug resistance, defined as lack of susceptibility to penicillin and at least two other non-ss-lactam classes of antimicrobial drugs, was observed in 16.0% of isolates. Resistance to all 10 ss-lactam drugs examined in this study was directly related to the level of penicillin resistance. Penicillin resistance rates were highest in isolates from middle ear fluid and sinus aspirates of children ambulatory-care settings. Twenty-four of the 34 medical centers in this study had participated in a similar study 3 years before. In 19 of these 24 centers, penicillin resistance rates increased 2.9% to 39.2%. Similar increases were observed with rates of resistance to other antimicrobial drugs.
Similar articles
-
Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999--2000, including a comparison of resistance rates since 1994--1995.Antimicrob Agents Chemother. 2001 Jun;45(6):1721-9. doi: 10.1128/AAC.45.6.1721-1729.2001. Antimicrob Agents Chemother. 2001. PMID: 11353617 Free PMC article.
-
Antimicrobial-drug use and changes in resistance in Streptococcus pneumoniae.Emerg Infect Dis. 2000 Sep-Oct;6(5):552-6. doi: 10.3201/eid0605.000519. Emerg Infect Dis. 2000. PMID: 10998390 Free PMC article. Clinical Trial.
-
Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States.N Engl J Med. 2000 Dec 28;343(26):1917-24. doi: 10.1056/NEJM200012283432603. N Engl J Med. 2000. PMID: 11136262
-
Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study.Antimicrob Agents Chemother. 1996 May;40(5):1208-13. doi: 10.1128/AAC.40.5.1208. Antimicrob Agents Chemother. 1996. PMID: 8723468 Free PMC article.
-
[The procedures for detection of penicillin-resistant Streptococcus pneumoniae and the epidemiology].Rinsho Byori. 2000 Jan;Suppl 111:48-55. Rinsho Byori. 2000. PMID: 10804792 Review. Japanese.
Cited by
-
Activities of clinafloxacin, gatifloxacin, gemifloxacin, and trovafloxacin against recent clinical isolates of levofloxacin-resistant Streptococcus pneumoniae.Antimicrob Agents Chemother. 2000 Nov;44(11):2962-8. doi: 10.1128/AAC.44.11.2962-2968.2000. Antimicrob Agents Chemother. 2000. PMID: 11036007 Free PMC article.
-
The role of antibacterial therapy of acute otitis media in promoting drug resistance.Paediatr Drugs. 2001;3(9):639-47. doi: 10.2165/00128072-200103090-00002. Paediatr Drugs. 2001. PMID: 11688595 Review.
-
PCR-based ordered genomic libraries: a new approach to drug target identification for Streptococcus pneumoniae.Antimicrob Agents Chemother. 2002 Aug;46(8):2507-12. doi: 10.1128/AAC.46.8.2507-2512.2002. Antimicrob Agents Chemother. 2002. PMID: 12121925 Free PMC article.
-
Genetic relatedness of levofloxacin-nonsusceptible Streptococcus pneumoniae isolates from North America.J Clin Microbiol. 2003 Jun;41(6):2458-64. doi: 10.1128/JCM.41.6.2458-2464.2003. J Clin Microbiol. 2003. PMID: 12791865 Free PMC article.
-
Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999--2000, including a comparison of resistance rates since 1994--1995.Antimicrob Agents Chemother. 2001 Jun;45(6):1721-9. doi: 10.1128/AAC.45.6.1721-1729.2001. Antimicrob Agents Chemother. 2001. PMID: 11353617 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous